The Effect of Aerobic and Resistance Training in Patients With Type 2 Diabetes on Vitamin D Treatment
Recruiting · NCT06081387 · Interventional (participants receive a specific treatment) · Lead sponsor: University Ramon Llull
View the official record on ClinicalTrials.gov →Interventions studied
Resistance training
What this trial is about
The purpose of this study protocol is to assess the effect of concurrent aerobic and resistance training in patients with type 2 diabetes on vitamin D treatment
Who can take part
Age range
40 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Adults (females or males) older than 18 years old with a diagnosis of T2D in the clinic database
- Patients who have been taking the combination therapy of metformin + sodium-glucose transport protein 2 inhibitors (iSGLT2), as recommended by the redGDPS 2023, with stable medication for the past 6 months.
- Diabetic patients taking prescribed VitD treatment for at least 6 months (intervention group) and diabetic patients not taking prescribed VitD (control group)
- Patients who signed the informed consent
- Patients capable of performing mild to moderate physical activity (to walk steadily and independently for at least 6 minutes)
Exclusion criteria
- Patients taking other medication different than metformin + iSGLT2 (including combinations and insulin)
- Patients taking polyvitaminic supplementation at the inclusion for at least, 1 month before the intervention
- Female subjects who are pregnant
- Patients who did not sign the informed consent
Where it is running
1 location listed.
- CAP Sant Rafael - Barcelona, Spain